StockData
EyePoint, Inc. logo

EyePoint, Inc. (EYPT) stock

EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.27−0.02 (-8.08%)

Close on Nov 18, 2026Market cap $23.45MP/E –Yield –

EyePoint operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

EyePoint's operating income for the twelve months ending Jun 30, 2026 was -$316.98M. For fiscal 2025 it was -$243.43M. The highest annual figure on record is $9.09M in fiscal 2010.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$243.43M–
FY2024Dec 31, 2024-$145.85M–
FY2023Dec 31, 2023-$75.07M–
FY2022Dec 31, 2022-$99.64M–
FY2021Dec 31, 2021-$55.28M–
FY2020Dec 31, 2020-$37.29M–
FY2018Jun 30, 2018-$26.27M–
FY2017Jun 30, 2017-$18.58M–
FY2016Jun 30, 2016-$21.77M-439.1%
FY2015Jun 30, 2015$6.42M–
FY2014Jun 30, 2014-$13.49M–
FY2013Jun 30, 2013-$12.03M–
FY2012Jun 30, 2012-$25.21M–
FY2011Jun 30, 2011-$10.00M-210.0%
FY2010Jun 30, 2010$9.09M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026-$97.38M–
Q1 FY2026CQ1 2026Mar 31, 2026-$87.23M–
Q4 FY2025CQ4 2025Dec 31, 2025-$70.35M–
Q3 FY2025CQ3 2025Sep 30, 2025-$62.03M–
Q2 FY2025CQ2 2025Jun 30, 2025-$62.23M–
Q1 FY2025CQ1 2025Mar 31, 2025-$48.84M–
Q4 FY2024CQ4 2024Dec 31, 2024-$45.24M–
Q3 FY2024CQ3 2024Sep 30, 2024-$32.75M–
Q2 FY2024CQ2 2024Jun 30, 2024-$34.55M–
Q1 FY2024CQ1 2024Mar 31, 2024-$33.32M–
Q4 FY2023CQ4 2023Dec 31, 2023-$16.35M–
Q3 FY2023CQ3 2023Sep 30, 2023-$14.40M–
Q2 FY2023CQ2 2023Jun 30, 2023-$22.76M–
Q1 FY2023CQ1 2023Mar 31, 2023-$21.55M–
Q4 FY2022CQ4 2022Dec 31, 2022-$43.74M–
Q3 FY2022CQ3 2022Sep 30, 2022-$18.40M–
Q2 FY2022CQ2 2022Jun 30, 2022-$19.22M–
Q1 FY2022CQ1 2022Mar 31, 2022-$18.28M–
Q4 FY2021CQ4 2021Dec 31, 2021-$18.05M–
Q3 FY2021CQ3 2021Sep 30, 2021-$15.31M–
Q2 FY2021CQ2 2021Jun 30, 2021-$10.98M–
Q1 FY2021CQ1 2021Mar 31, 2021-$10.94M–
Q4 FY2020CQ4 2020Dec 31, 2020-$12.74M–
Q3 FY2020CQ3 2020Sep 30, 2020-$1.96M–
Q2 FY2020CQ2 2020Jun 30, 2020-$11.15M–
Q1 FY2020CQ1 2020Mar 31, 2020-$11.44M–
Q4 FY2018CQ2 2018Jun 30, 2018-$9.78M–
Q3 FY2018CQ1 2018Mar 31, 2018-$4.68M–
Q2 FY2018CQ4 2017Dec 31, 2017-$5.81M–
Q1 FY2018CQ3 2017Sep 30, 2017-$6.01M–
Q4 FY2017CQ2 2017Jun 30, 2017-$6.14M–
Q3 FY2017CQ1 2017Mar 31, 2017-$5.16M–
Q2 FY2017CQ4 2016Dec 31, 2016-$94.00K–
Q1 FY2017CQ3 2016Sep 30, 2016-$7.19M–
Q4 FY2016CQ2 2016Jun 30, 2016-$6.46M–
Q3 FY2016CQ1 2016Mar 31, 2016-$5.10M–
Q2 FY2016CQ4 2015Dec 31, 2015-$5.24M–
Q1 FY2016CQ3 2015Sep 30, 2015-$4.98M–
Q4 FY2015CQ2 2015Jun 30, 2015-$5.20M–
Q3 FY2015CQ1 2015Mar 31, 2015-$5.05M–

More EyePoint figures

See a number that looks wrong?